Tianasen

N/A

Report date: 2026/01/27 20:00:10
NME

Base Information

Drug NameTianasen
Drug Alias NameASO-GNAO1
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionG Protein Subunit Alpha O1 modulators
TargetsG Protein Subunit Alpha O1
Therapy Area/IndicationsHyperkinesisEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPirogov Russian National Research Medical University
China Registration ClassN/A

Develop Information

Active CompaniesPirogov Russian National Research Medical University
Inactive CompaniesN/A
Active IndicationsHyperkinesisEpilepsy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A